Feed / Theme
Confirmed

Healthcare Biotech

72 names are moving together; 39% are participating in the current session.

Co-movement

Observed intraday paths are not available for this group yet.

Members

TICKERCompanySectorTodayObserved activity
GMGeneral Motors CompanyConsumer Cyclical-1.4%Group member
GPGIGPGI, Inc.Industrials-2.0%Group member
GRALGRAIL, Inc.Healthcare-0.2%Group member
GFIGold Fields LimitedBasic Materials-1.8%Group member
GRMNGarmin Ltd.Technology+0.2%Group member
GEOGeo Group Inc (The) REITIndustrials-0.7%Group member
BBVABanco Bilbao Vizcaya ArgentariaFinancial Services-1.2%Group member
FCHLFitness Champs Holdings LimitedConsumer Defensive-7.5%Group member
SENSSenseonics Holdings, Inc.Healthcare-1.9%Group member
GRPNGroupon, Inc.Communication Services-10.1%Group member
HWMHowmet Aerospace Inc.Industrials+0.1%Group member
BCBrunswick CorporationConsumer Cyclical-1.4%Group member
GSMFerroglobe PLCBasic Materials+1.2%Group member
BLKBlackRock, Inc.Financial Services-0.5%Group member
HASIHA Sustainable Infrastructure CFinancial Services+0.3%Group member
BATLBattalion Oil CorporationEnergy+17.7%Group member
RHLDResolute Holdings ManagementIndustrials-8.3%Group member
HEIHeico CorporationIndustrials-1.9%Group member
BCSBarclays PLCFinancial Services-0.7%Group member
BBIOBridgeBio Pharma, Inc.Healthcare-3.4%Group member
NWGNatWest Group plcFinancial Services-1.4%Group member
CDRECadre Holdings, Inc.Industrials-2.8%Group member
SLSSELLAS Life Sciences Group, IncHealthcare-0.8%Group member
BNYThe Bank of New York Mellon CorFinancial Services-0.4%Group member

Why we believe this

Cohort

72 names

Participation

39% this session

Observed history

1 daily builds

Filing coverage

55/72 members

credit / rates affecting interest expense

The following table summarizes the components impacting Interest expense, net (in millions): Three Months Ended March 31, 2026 2025 Interest expense on third-party borrowings (1) $ 146 $ 109 Interest expense on related party promissory notes (2) 23 20 Capitalized interest (2) (2) $ 167 $ 127 (1) The increase in interest expense for the three-month 2026 period compared to the same period in 2025 was primarily driven by higher weighted-average debt outstanding in the 2026 period from (i) the issuance of an aggregate of $3.0 billion of senior notes during 2025 and (ii) higher commercial paper and term loan borrowings in the 2026 period, primarily related to the funding of the Cactus III acquisition in November 2025, partially offset by (iii) the repayment of $1.0 billion of senior notes in October 2025.

PAA 10-Q

demand / volume

In Asia, softer demand—across Paper Machine Clothing & Engineered Fabrics—contributed to regional pressure, while EF also declined due to strategic divestment and planned plant consolidation in Europe.

AIN 10-K

restructuring affecting expense

In addition, tax expense was impacted by our continued progression of certain planning and restructuring activities within our organizational structure in connection with the pending Canadian NGL Business divestiture.

PAA 10-Q

Healthcare Biotech can stay leader-led if APO and the next software names fail to join while PAA keeps moving.

Connected, outside the group

No high-confidence filing-linked non-members are available for this group yet.

History

Historical cohort observations are not available yet.